ICU Medical, Inc. (NASDAQ: ICUI) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $4.4B. The Maz Rating grades it against the other companies in its sector.
ICU Medical, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $176.91, ICU Medical, Inc. trades at 74.3x trailing earnings, 2.1x sales and 2.0x book value, with an EV/EBITDA of 18.5. Over the last twelve months it generated about $2.2B of revenue and $60M of net income. It runs a gross margin of 38.7%, an operating margin of 6.8% and a net margin of 2.8%. It shows return on equity of 2.8%, return on invested capital of 4.3% and a free cash flow yield of 4.7%. On the balance sheet: a debt-to-equity ratio of 0.53 and a current ratio of 2.37. Over the past 52 weeks the share price ranged from $113.37 to $192.85, with a beta of 0.76.
ICU Medical, Inc. does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 1 Strong Buy, 10 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.